ASC means there are unusual cells found on the surface of the cervix, the lower part of the uterus. These cells don't look normal and might be caused by an infection like HPV. It's important to get checked by a doctor, as it could be a sign of something more serious, like cancer, or just a harmless growth. Further tests are usually needed.
Every report comes from a Lived member, sent anonymously.
No reports yet
Add what worked for you with the search bar below
Atypical squamous cells (ASC) is a Pap test result meaning that some of the flat, skin-like cells covering the cervix look slightly abnormal under the microscope, but not abnormal enough to be called a definite lesion. The cervix is the lower, narrow end of the uterus that opens into the vagina. An ASC result is not a cancer diagnosis. It is a signal that the cells need a closer look or a repeat test. There are two kinds of ASC result, and the difference matters. ASC-US (atypical squamous cells of undetermined significance) is the most common abnormal Pap result. It often reflects a human papillomavirus (HPV) infection, but it can also come from irritation, infection or hormone changes, and most people with it do not have serious cell changes. ASC-H (atypical squamous cells, cannot exclude a high-grade squamous intraepithelial lesion) means some cells look concerning enough that a high-grade change, the kind more likely to become cancer if left alone, cannot be ruled out. ASC-H is less common and is followed up more closely.
Infection with a high-risk type of HPV is the main reason cervical cells look abnormal. HPV spreads through intimate skin-to-skin contact, usually during sex, and is very common. Most infections cause no symptoms, and the immune system usually clears them within a year or two. The cells then usually return to normal. Other things can make cells look atypical without any link to cancer, including irritation, infections such as a yeast infection, polyps and the hormone shifts of pregnancy or menopause. Low estrogen after menopause is a common example. What raises concern is HPV that persists for years, because persistent infection is what can gradually turn normal cells into precancer. A weakened immune system, for example from HIV or medicines taken after a transplant or for autoimmune disease, makes persistence more likely. Smoking, including secondhand smoke, also raises the risk of cervical cancer.
ASC is found on a Pap test (cervical cytology), in which a clinician brushes cells from the cervix and a lab examines them. Because the result itself is uncertain, the next step is to find out whether it reflects anything important. US doctors follow risk-based guidelines from the American Society for Colposcopy and Cervical Pathology (ASCCP) that weigh the current result, the HPV result, past results and age. After ASC-US, the same sample is usually tested for high-risk HPV. If HPV is negative, the chance of a serious change is low, and repeat testing in about three years is typically recommended. If HPV is positive, a colposcopy is usually advised. For someone whose HPV test or cotest (HPV and Pap together) was negative within roughly the past five years, a repeat test in one year is usually enough instead. After ASC-H, colposcopy is recommended whatever the HPV result, because a high-grade change is found often enough that waiting is not advised. Colposcopy is an office exam in which the clinician uses a magnifying instrument with a light to look closely at the cervix after applying a vinegar solution that highlights abnormal areas. Small biopsies are taken from any area that looks abnormal. The biopsy result, graded as cervical intraepithelial neoplasia (CIN) 1, 2 or 3, shows what is actually present. CIN 1 is mild; CIN 2 and 3 are high-grade precancer. Some groups follow different rules. People younger than 25 with ASC-US usually repeat the Pap test at one and two years rather than going straight to colposcopy, since their changes very often clear on their own. People with HIV or other immune suppression are usually sent for colposcopy after HPV-positive ASC-US. In pregnancy, the same thresholds for colposcopy apply.
ASC itself is usually not treated. Most of the time the plan is watchful follow-up: repeat HPV or Pap testing at set intervals, or a colposcopy to look for changes that do need attention. If HPV is negative and low hormone levels after menopause may explain the cells, a clinician may suggest a short course of vaginal estrogen cream before repeating the test. Treatment is aimed at high-grade precancer (CIN 2 or 3) confirmed by biopsy, with the goal of removing or destroying those cells before they can become cancer. The most common approach is LEEP (loop electrosurgical excision procedure), an office procedure under local anesthetic in which a thin, electrically heated wire loop removes the abnormal area. A cone biopsy removes a similar cone-shaped piece with a scalpel in a hospital. Freezing (cryotherapy) or laser treatment destroy abnormal tissue instead of removing it. Mild changes (CIN 1) usually clear on their own and are watched rather than treated. The main trade-off concerns future pregnancy. Removing tissue can rarely weaken the cervix and raise the risk of miscarriage or premature birth, which is why people under 25 or planning a pregnancy may be monitored longer for moderate changes. High-grade changes found during pregnancy are usually watched and treated after delivery. The HPV vaccine (Gardasil 9) does not treat an existing infection, but it protects against other high-risk HPV types and is sometimes offered to adults up to 45 during treatment for CIN 2 or 3.
For most people with ASC-US, the story ends quietly: the HPV infection clears, follow-up tests come back normal, and routine screening resumes. Even when HPV persists or a colposcopy finds mild changes, the usual outcome is more frequent testing rather than treatment. Cervical cancer develops slowly, over years, which is why a schedule of repeat tests is a safe strategy rather than a delay. ASC-H carries more uncertainty, and a colposcopy and biopsy are what resolve it. Many people with ASC-H turn out to have mild or no changes, while others have high-grade precancer that is then treated. Colposcopy feels similar to a Pap test, though a biopsy can cause brief cramping and some spotting or discharge for a few days. After treatment for precancer, follow-up continues for years, starting with an HPV test about six months later. Even after normal results, the timing of future screening usually stays closer than average for a while. The real risk lies in missed follow-up. Cervical cancer is rare in people who are screened regularly and complete the recommended next steps. An abnormal result can cause worry, and it is reasonable to ask what the specific result means for you and what the next test will show.
Make sure you know which next step your result calls for and when it is due, and contact your care team if you have not heard about a result or a follow-up appointment. If you have had abnormal results before, or you have HIV or another cause of weakened immunity, bring this up so the plan accounts for it. Contact your care team promptly about vaginal bleeding after sex, between periods or after menopause, periods that become unusually heavy or long, watery, bloody or foul-smelling discharge, or pelvic pain or pain during sex. These symptoms have many causes, but they should not wait for the next scheduled test. After a colposcopy biopsy, call your care team right away for heavy bleeding (soaking more than one pad an hour), severe lower belly pain, fever or chills.
Last reviewed • Oct 2026
Educational content, not medical advice.
Share what living with Atypical Squamous Cells of the Cervix (ASC) is like, what's helped you, or ask the community a question.